The Effect of Dexmedetomidine on Microcirculation in Septic Shock
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2018
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Septic shock
- Focus Therapeutic Use
- 15 May 2017 Status changed from recruiting to completed.
- 17 Nov 2015 Planned End Date changed from 1 Oct 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 17 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.